Cost-effectiveness analyses

Comment

C M Clark. Ann Intern Med. 2001.

. 2001 Sep 4;135(5):382-3.

doi: 10.7326/0003-4819-135-5-200109040-00021.

No abstract available

Comment on

Cost-effectiveness of cholesterol-lowering therapies according to selected patient characteristics.
Prosser LA, Stinnett AA, Goldman PA, Williams LW, Hunink MG, Goldman L, Weinstein MC. Prosser LA, et al. Ann Intern Med. 2000 May 16;132(10):769-79. doi: 10.7326/0003-4819-132-10-200005160-00002. Ann Intern Med. 2000. PMID: 10819699
Cost-effectiveness of 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor therapy in older patients with myocardial infarction.
Ganz DA, Kuntz KM, Jacobson GA, Avorn J. Ganz DA, et al. Ann Intern Med. 2000 May 16;132(10):780-7. doi: 10.7326/0003-4819-132-10-200005160-00003. Ann Intern Med. 2000. PMID: 10819700